ABEONA THERAPEUTICS INC (ABEO)
US00289Y2063 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 14.47M | 14.20M | 32.90M | 12.60M | 129.30M | |||
| Marketable Securities | 37.75M | 37.90M | 12.10M | 82.40M | 0.00 | |||
| Receivables | 2.44M | 200.00K | 3.00M | N/A | 0.00 | |||
| Other Current Assets | 1.07M | 700.00K | 7.40M | 2.70M | 3.10M | |||
| Total Current Assets | 55.74M | 53.10M | 55.40M | 97.70M | 132.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.99M | 11.10M | 21.70M | 18.40M | 21.20M | |||
| Goodwill | N/A | N/A | 0.00 | 32.50M | 32.50M | |||
| Intangibles | N/A | 0.00 | 1.40M | 1.50M | 36.20M | |||
| Other Non-Current Assets | 277.00K | 0.00 | 1.10M | 1.10M | 1.10M | |||
| Total Non-Current Assets | 8.26M | 11.10M | 24.20M | 53.50M | 91.00M | |||
| TOTAL ASSETS | 64.00M | 64.20M | 79.60M | 151.20M | 223.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 300.00K | N/A | |||
| Accrued Expenses | 6.98M | 5.80M | 7.40M | 5.10M | 7.20M | |||
| Accounts Payable | 1.86M | 1.80M | 4.30M | 4.70M | 3.80M | |||
| Other Current Liabilities | 4.58M | 200.00K | 4.90M | 31.80M | 27.70M | |||
| Total Current Liabilities | 13.42M | 7.80M | 16.60M | 42.00M | 38.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 1.40M | 0.00 | |||
| Other Non-Current Liabilities | 35.75M | 29.70M | 11.60M | 5.30M | 6.30M | |||
| Total Non-Current Liabilities | 35.75M | 29.70M | 11.60M | 6.60M | 6.30M | |||
| TOTAL LIABILITIES | 49.18M | 37.50M | 28.20M | 48.60M | 45.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -749.52M | -695.30M | -655.60M | -570.70M | -486.50M | |||
| Additional Paid In Capital | 764.15M | 722.00M | 705.60M | 672.30M | 664.10M | |||
| Common Shares | 265.00K | 200.00K | 1.50M | 1.00M | 800.00K | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -66.00K | -100.00K | 0.00 | 0.00 | N/A | |||
| Shares Outstanding | 26.52M | 17.70M | 5.90M | 3.80M | 3.30M | |||
| Tangible Book Value per Share | 0.56 | 1.51 | 8.47 | 18.05 | 33.24 | |||
| Total Shareholders' Equity | 14.83M | 26.80M | 51.40M | 102.60M | 178.40M | |||
| TOTAL LIABILITIES AND EQUITY | 64.00M | 64.20M | 79.60M | 151.20M | 223.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.01 | N/A | |||
| Current Ratio | 4.15 | 6.81 | 3.34 | 2.33 | 3.42 | |||
| Return On Assets (ROA) | -84.67% | -67.73% | -106.71% | -55.71% | -34.15% | |||
| Return On Equity (ROE) | -365.49% | -162.24% | -165.25% | -82.10% | -42.76% | |||
All data in USD